MAPK3 and pulmonary hypertension: In our experimental model, pulmonary hypertension activates ERK1/2 and p38 MAPK, but sildenafil partially suppresses their activation ultimately preventing the progression of vascular remodeling and inflammation in PH that is completely in line with the aforementioned findings.